Somascan assays and somasignal tests, an INNOVATIVE7000 analyte multiplex proteomics platform service

Ended Purchase Order Awarded Last action

Contract number
75N98021P01560
Awardee
Awarding agency
Obligated
$58,800

Award facts

Contract value 100% obligated
$58,800.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
621511 Medical Laboratories
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Boulder, CO 80301, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$11,200
Original award $70,000

About this award

The U.S. Office of Logistics and Acquisition Operations awarded a $58.8K firm fixed-price purchase order to SomaLogic Operating Co., Inc. (doing business as CM Life Sciences II Inc.) on April 29, 2021, with completion targeted for July 31, 2021. The contract covers SomaScan assays and SomaSignal tests utilizing SomaLogic's innovative 7,000-analyte multiplex proteomics platform service, to be performed at the contractor's facility in Boulder, Colorado. This award does not utilize a set-aside designation and represents a standard commercial acquisition of specialized proteomics analysis services.

SomaLogic is a commercial-stage proteomics company specializing in high-throughput protein measurement and biomarker discovery using proprietary aptamer-based assay technology. The company has established itself as a critical technology partner for federal research institutions, particularly within the Department of Health and Human Services, including the National Institutes of Health, Food and Drug Administration, and Department of Veterans Affairs. SomaLogic's SomaScan platform enables simultaneous measurement of up to 11,000 proteins in biological samples with high sensitivity and reproducibility, supporting research across neurodegenerative diseases, cardiovascular health, cancer, infectious diseases, and immunology. This purchase order represents continued federal investment in SomaLogic's proteomics capabilities for research and biomarker discovery initiatives.

Quick answers

Who was awarded contract 75N98021P01560?

75N98021P01560 was awarded to Somalogic Operating Co., Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on April 29, 2021.

How much is contract 75N98021P01560 worth?

The government has obligated $58,800 on 75N98021P01560.

Was contract 75N98021P01560 competed?

The extent of competition for 75N98021P01560 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award